studi
present
multipl
detect
respiratori
virus
infant
primari
respiratori
ill
investig
sensit
nasal
swab
nasopharyng
aspir
assess
whether
patient
characterist
viral
load
play
role
sensit
healthi
infant
includ
sign
first
respiratori
tract
infect
pair
nasopharyng
aspir
nasal
swab
collect
realtim
polymeras
chain
reaction
pcr
carri
respiratori
pathogen
pair
nasopharyng
aspir
nasal
swab
collect
infant
rhinoviru
respiratori
syncyti
viru
frequent
detect
coinfect
occur
infant
sensit
nasal
swab
lower
nasopharyng
aspir
particular
respiratori
syncyti
viru
vs
rhinoviru
vs
sensit
nasal
swab
strongli
determin
cycl
threshold
ct
valu
p
sensit
swab
respiratori
syncyti
viru
rhinoviru
children
sever
symptom
score
conclud
communitybas
studi
surveil
purpos
nasal
swab
use
though
sensit
lower
aspir
particular
detect
mild
case
respiratori
syncyti
viru
rsv
infect
nasal
swab
npa
nasopharyng
aspir
pcr
polymeras
chain
reaction
hmpv
human
metapneumoviru
rsv
respiratori
syncyti
viru
respiratori
virus
common
caus
ill
children
particular
first
year
life
may
lead
sever
morbid
hospitalis
differ
type
specimen
avail
viral
diagnosi
nasopharyng
aspir
npa
consid
best
sampl
techniqu
invas
result
significantli
distress
infant
nasal
swab
ns
number
studi
compar
sensit
npa
nasopharyng
swab
nosethroat
swab
ns
gener
convent
techniqu
viral
cultur
antigen
detect
method
use
use
realtim
polymeras
chain
reaction
pcr
may
overcom
differ
sensit
respiratori
virus
result
specimen
type
limit
data
avail
comparison
sampl
method
combin
realtim
pcr
observ
nosethroat
swab
less
invas
diagnost
techniqu
adequ
sensit
use
outpati
larg
communitybas
set
children
howev
test
perform
rhinoviru
even
though
viru
commonli
infect
infant
aim
studi
present
detect
common
respiratori
pathogen
infant
primari
respiratori
ill
investig
sensit
ns
npa
assess
role
patient
characterist
viral
load
sensit
either
sampl
method
studi
part
netherland
amnion
fluid
studi
utrecht
univers
medic
centr
uumc
netherland
healthi
infant
includ
birth
risk
primari
respiratori
infect
age
one
year
data
collect
episod
sampl
stop
one
year
birth
april
april
includ
two
winter
season
pair
npa
ns
specimen
obtain
infant
parent
instruct
notifi
clinic
staff
within
h
onset
symptom
clinic
staff
visit
child
within
h
histori
ill
taken
standardis
questionnair
symptom
score
accord
gern
et
al
point
present
parenthes
fever
cough
mild
moder
sever
rhinorrhoea
mild
moder
sever
hoars
durat
ill
day
apnoea
wheez
retract
tachypnoea
cyanosi
mild
moder
sever
infect
defin
sum
score
higher
respect
special
train
clinic
staff
obtain
pair
ns
npa
npa
obtain
use
infant
mucu
extractor
vygon
nostril
suction
addit
ns
collect
sampl
collect
one
nostril
one
hard
palat
use
separ
cottontip
swab
infant
mucu
extractor
vygon
pharmaceutiqu
ecouen
franc
two
swab
insert
one
vial
contain
ml
viru
transport
medium
gli
medium
semiquantit
realtim
pcr
conduct
ns
npa
respiratori
syncyti
viru
rsv
rhinoviru
human
metapneumoviru
adenoviru
coronaviru
influenza
parainfluenza
viru
type
parainfluenza
type
bocaviru
mycoplasma
pneumonia
chlamydia
pneumonia
nucleic
acid
extract
use
qiaamp
dsp
viru
kit
qiagen
valencia
ca
usa
sampl
elut
buffer
cdna
synthesis
use
multiscrib
revers
transcriptas
rt
random
hexam
appli
biosystem
foster
citi
ca
usa
reaction
mixtur
contain
cdna
mix
elut
rna
incub
min
rt
carri
min
follow
rt
inactiv
min
sampl
assay
reaction
mixtur
contain
c
dna
mix
forward
revers
primer
probe
sampl
spike
extract
intern
control
viru
murin
encephalomyocard
viru
rna
phocin
herp
viru
dna
amplif
detect
perform
use
abi
prism
sequencedetect
system
min
acquir
optim
amperas
ung
activ
min
activ
amplitaq
gold
dna
polymeras
follow
cycl
min
primer
probe
realtim
pcr
detect
rsv
influenza
viru
parainfluenza
viru
adenoviru
avail
van
de
pol
et
al
realtim
pcr
assay
perform
describ
previous
similar
previou
studi
consensu
standard
use
assess
sensit
test
method
posit
result
either
npa
ns
consid
gold
standard
presenc
pathogen
use
calcul
sensit
npa
ns
detect
respiratori
pathogen
chisquar
test
use
logist
regress
analysi
perform
outcom
variabl
defin
sampl
posit
variabl
use
model
age
gender
symptom
score
multipl
viru
detect
statist
signific
conclud
pvalu
statist
analys
perform
stata
statacorp
lp
colleg
station
tx
usa
total
respiratori
pathogen
identifi
children
major
children
ill
less
day
time
sampl
median
age
primari
infect
day
rang
median
score
symptom
indic
mild
ill
tabl
children
ill
day
longer
one
pathogen
detect
children
one
pathogen
detect
rhinoviru
rsv
four
coronaviru
two
hmpv
two
parainfluenza
viru
type
one
bocaviru
children
two
pathogen
detect
rhinoviru
rsv
children
two
pathogen
detect
first
episod
respiratori
symptom
three
pathogen
n
four
pathogen
five
pathogen
coinfect
rate
pathogen
rhinoviru
hmpv
rsv
coronaviru
bocaviru
sensit
nasal
swab
lower
aspir
rsv
rhinoviru
rhinoviru
found
frequent
follow
rsv
coronaviru
tabl
influenza
virus
parainfluenza
type
virus
detect
sensit
detect
pathogen
npa
ci
wherea
sensit
ns
lower
ci
detect
rsv
rhinoviru
sensit
ns
lower
npa
tabl
sensit
valu
npa
ns
investig
detail
rhinoviru
rsv
tabl
children
low
symptom
score
sensit
ns
lower
npa
ns
lower
sensit
npa
cycl
threshold
ct
valu
assess
whether
sensit
ns
differ
age
group
gender
multipl
pathogen
symptom
score
ct
valu
chisquar
test
perform
sensit
ns
detect
rsv
relat
symptom
score
sensit
logist
regress
analysi
age
gender
significantli
predict
detect
rsv
rhinoviru
symptom
score
predict
rsv
detect
npa
odd
ratio
ci
ns
ci
invers
relationship
observ
symptom
score
rhinoviru
detect
two
sampl
ci
presenc
one
pathogen
predict
rsv
ci
rhinoviru
detect
ci
npa
analysi
perform
backward
regress
p
result
chang
studi
illustr
proport
infant
respiratori
pathogen
detect
high
coinfect
common
children
two
pathogen
detect
first
episod
respiratori
symptom
coinfect
observ
frequent
rsv
coronaviru
bocaviru
particular
high
rate
coinfect
young
children
describ
recent
childhood
pneumonia
particular
children
age
less
month
children
hospitalis
acut
respiratori
tract
infect
frequent
detect
viru
rsv
follow
human
bocaviru
rhinoviru
common
combin
report
rsv
bocaviru
even
though
high
occurr
coinfect
report
rang
studi
present
even
higher
rate
coinfect
possibl
explan
high
coinfect
rate
may
relat
sampl
nostril
npa
human
bocaviru
newli
identifi
viru
detect
respiratori
tract
secret
patient
acut
respiratori
symptom
sampl
coinfect
anoth
viru
observ
bocavirusposit
children
frequent
associ
bocaviru
respiratori
virus
might
explain
persist
bocaviru
respiratori
tract
furthermor
investig
sensit
npa
ns
test
realtim
pcr
method
sensit
npa
ns
particular
detect
rhinoviru
rsv
ns
lower
sensit
respect
compar
npa
respect
sensit
ns
rsv
children
high
symptom
score
rsv
rhinoviru
viral
load
indic
ct
valu
major
determin
sensit
ns
dosedepend
fashion
symptom
score
predict
rsv
detect
npa
ns
invers
relationship
observ
symptom
score
rhinoviru
detect
two
sampl
use
swab
consid
suitabl
replac
communitybas
research
epidemiolog
studi
major
advantag
swab
collect
less
pain
conveni
aspir
addit
devic
need
factor
may
outweigh
reduct
sensit
advantag
molecular
method
detect
respiratori
virus
report
lambert
et
al
report
use
method
seem
overcom
previous
observ
sensit
reduct
less
invas
specimen
combin
convent
laboratori
method
recent
develop
flock
swab
sensit
even
improv
flock
swab
advantag
rapid
less
traumat
paediatr
patient
howev
sensit
flock
swab
outpati
respiratori
tract
infect
may
lower
hospitalis
patient
studi
requir
consid
differ
type
swab
patient
popul
test
broad
spectrum
respiratori
pathogen
find
demonstr
lower
sensit
ns
particular
rsv
similar
result
report
studi
convent
nonamplificationbas
method
use
lambert
et
al
test
rhinoviru
frequent
detect
viru
studi
elsewher
influenza
detect
found
studi
explain
sampl
bia
swab
taken
npa
nasopharyng
aspir
ns
nasal
swab
rsv
respiratori
syncyti
viru
ct
cycl
threshold
valu
onesid
confid
interv
use
case
sensit
b
ctvalu
npa
use
refer
compar
ns
therefor
sensit
npa
categori
winter
season
rsv
influenza
peak
incid
possibl
reason
may
relat
patient
popul
small
popul
size
anoth
studi
show
similar
result
rhinoviru
rsv
frequent
detect
number
limit
studi
firstli
one
limit
time
sampl
five
case
sampl
occur
day
onset
ill
sinc
viral
shed
rsv
highest
day
sampl
prefer
occur
period
high
proport
posit
sampl
howev
indic
effect
major
drawback
studi
secondli
studi
pain
discomfort
collect
sampl
assess
studi
provid
refer
final
unknown
whether
order
obtain
specimen
may
result
lower
detect
rate
ns
possibl
suction
nostril
npa
secret
viru
viral
nucleic
acid
reduc
correspond
find
mild
case
detect
ns
sensit
ns
drop
lower
symptom
score
higher
ct
valu
order
natur
sampl
collect
slightli
differ
studi
perform
lambert
et
al
sensit
ns
may
underestim
caution
need
taken
interpret
ns
sensit
rsv
rhinoviru
commonli
detect
infant
primari
respiratori
infect
coinfect
occur
half
children
sensit
npa
higher
ns
particular
detect
rsv
rhinoviru
although
sensit
method
import
one
must
also
take
account
advantag
differ
sampl
method
offer
great
advantag
ns
method
perform
outpati
set
without
need
special
devic
less
costli
caus
less
distress
patient
npa
although
reduct
sensit
rsv
particularli
infant
mild
symptom
ns
conveni
sampl
patient
commun
studi
use
surveil
purpos
